Aminopterin

N/A

Report date: 2026/01/12 20:00:53
NME

Base Information

Drug NameAminopterin
Drug Alias Nameaminopterina de白血宁氨蝶呤Rac-aminopterin氨喋呤 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsPsoriasisArthritis, RheumatoidEndometrial Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUkraine
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyntrix Biosystems IncGenzyme CorpRutgers University
Active IndicationsN/A
Inactive IndicationsPsoriasisArthritis, RheumatoidEndometrial Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG